Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 79,398	$ 49,898
Current portion of security deposits		254
Prepaid expenses and other current assets	4,248	4,234
Total current assets	83,646	54,386
Noncurrent portion of security deposits	253
Operating lease right-of-use asset	2,792	447
TOTAL ASSETS	86,691	54,833
CURRENT LIABILITIES:
Current portion of operating lease liabilities	406	429
Accounts payable	4,433	1,742
Accrued expenses and other current liabilities	16,143	15,286
Warrant liabilities	6,314	53,725
Total current liabilities	27,296	71,182
NONCURRENT LIABILITIES:
Noncurrent portion of operating lease liabilities	2,389	38
Clinical holdback - long-term portion		759
Total noncurrent liabilities	2,389	797
Total liabilities	29,685	71,979
Commitments and Contingencies (Note 15)
STOCKHOLDERS' (DEFICIT)/EQUITY:
Common stock, $0.0001 par value; 250,000,000 shares authorized as of December 31, 2024 and 200,000,000 shares authorized as of December 31, 2023; 137,228,741 shares issued and outstanding as of December 31, 2024 and 84,869,832 shares issued and outstanding as of December 31, 2023	35	8
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 0 shares issued and outstanding as of December 31, 2024 and December 31, 2023	0	0
Additional paid-in capital	631,181	451,432
Accumulated deficit	(574,210)	(468,586)
Total stockholders' equity/(deficit)	57,006	(17,146)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIT)	$ 86,691	$ 54,833